CellGenix® rh OSM
CellGenix Recombinant Human OSM promotes the differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) derived hepatoblasts into hepatocytes. It is produced in our dedicated animal-free facility ensuring maximum safety for optimal use in ATMP manufacturing.
Oncostatin M (OSM) is a cytokine belonging to the interleukin-6 (IL-6) subfamily and it most closely resembles leukemia inhibitory factor (LIF) in both structure and function. It is primarily produced by T cells and monocytes. OSM plays an important role in liver development, hematopoiesis, and inflammation, and also has been shown to be associated with bone formation and resorption.
The final manufacturing steps and quality control of all our preclinical grade products are performed in a GMP facility ensuring a consistent high quality.
CellGenix® Recombinant Human Oncostatin M
CellGenix® Preclinical rh OSM
CellGenix® rh OSM
- Produced in our dedicated animal-free facility
- High purity, activity and product stability
- Differentiation of ESCs and iPSCs into hepatocytes
Expressed in E. coli
Human OSM, accession #P13725, Ala26-Arg221
Lyophilized from a 0.2 µm-filtered solution in PBS
Final manufacturing steps and Quality Control (QC) are performed in a GMP facility.
|Molecular weight||22.1 kDa|
|Purity||≥ 95% as determined by SDS-PAGE|
|Activity||> 40 x 106 IU/mg, calibrated against NIBSC #93/564|
|Endotoxin level||< 1000 EU/mg|
|Intended use||Intended for preclinical ex vivo use. Not intended for human in vivo application.|
Recommended in sterile water to a final concentration of 250 µg/ml.
Ambient temperature. Please refer to Technote to learn more about our shipment validation procedure.
3 years from date of shipment.
Storage & Stability
Store lyophilized cytokine at -20°C to -80°C.
Avoid repeated freeze/thaw cycles.